Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
Medtech

Maria Rankka Named New Chair of Bico Group Board

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Medtech Magazine
medtech related image for: Maria Rankka Named New Chair of Bico Group Board

Photo by Nico Smit on Unsplash

Key takeaways

  • Maria Rankka has been appointed the new Chairperson of the Board for Bico Group, marking a significant leadership transition
  • This appointment follows the departure of her predecessor, Rolf Classon, who is stepping down from his board position for health reasons
  • Rankka, who joined the Bico board in May of this year, will now lead the board's strategic initiatives
Maria Rankka has been appointed the new Chairperson of the Board for Bico Group, marking a significant leadership transition. This appointment follows the departure of her predecessor, Rolf Classon, who is stepping down from his board position for health reasons. Rankka, who joined the Bico board in May of this year, will now lead the board's strategic initiatives. Her term as Chairperson will continue until the next annual general meeting, at which point a new board will be elected. Rankka brings a diverse and robust background to her new role. She currently serves as the Chairperson of Cellcolabs and is a co-founder of ABC Labs, bringing valuable entrepreneurial experience to Bico. Previously, she held the position of CEO for the Stockholm Chamber of Commerce, offering her deep insights into business and economic dynamics. In a press release, Rankka emphasized Bico's critical role in assisting pharmaceutical companies, biopharma, and academic institutions in accelerating innovations to foster healthier societies. Reflecting on her personal connection to Bico's work, Rankka highlighted her experience during the pandemic. "During the pandemic, I myself experienced the power of automating labs using both hardware and software," she stated. This firsthand experience reinforces her belief in the value of Bico's technological solutions. She expressed her enthusiasm for deepening her involvement with the company, adding, "I look forward to increasing my commitment now and actively contributing in my new role to Bico's continued journey."

Related Topics

Bico GroupMaria RankkaBoard ChairpersonMedtech LeadershipInnovation AccelerationLab Automation

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original